H
BIIB icon

Hexavest’s Biogen BIIB Stock Holding History

Hexavest’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26
Closed -$9K – 228
2021
Q2 		$9K Sell
26
-32,879
-100% -$9.96M ﹤0.01% 312
2021
Q1 		$9.21M Sell
32,905
-9,168
-22% -$2.47M 0.41% 84
2020
Q4 		$10.3M Sell
42,073
-19,724
-32% -$5.09M 0.39% 84
2020
Q3 		$17.5M Sell
61,797
-9,945
-14% -$2.77M 0.47% 67
2020
Q2 		$19.2M Sell
71,742
-9,248
-11% -$2.78M 0.44% 62
2020
Q1 		$25.6M Sell
80,990
-13,127
-14% -$3.98M 0.45% 75
2019
Q4 		$27.9M Sell
94,117
-1,432
-1% -$397K 0.34% 107
2019
Q3 		$22.2M Sell
95,549
-497
-0.5% -$116K 0.3% 108
2019
Q2 		$22.5M Sell
96,046
-3,412
-3% -$788K 0.3% 108
2019
Q1 		$23.5M Buy
99,458
+5,919
+6% +$1.86M 0.3% 107
2018
Q4 		$28.1M Buy
+93,539
New +$29.9M 0.41% 83

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hexavest's BIIB Position: Q3 2021 in Review

Hexavest sold out of Biogen (BIIB) in Q3 2021, closing a stake of 26 shares — an estimated $9K sold.

Hexavest first reported a position in BIIB in Q4 2018 and held it in 11 quarters. The position peaked at $28.1M in Q4 2018. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Hexavest reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Hexavest sold 26 Biogen shares in Q3 2021, an estimated $9K.
  • Hexavest first reported a position in Biogen in Q4 2018 and held it in 11 quarters.
  • Hexavest's Biogen position peaked at $28.1M in Q4 2018.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.